Tanshinone 11A also inhibited OSA growth by targeting AMPk-NRF2 pathway, knockdown of both NFE2L2/NRF2 and AMPK showed same effects as the drug (81). This evidence concerns the gene NFE2L2 and obstructive sleep apnea syndrome.